MedGenesis Therapeutix (MedGenesis) is a privately-held biopharmaceutical company committed to developing and commercializing highly innovative treatments for patients with serious neurologic disease. MedGenesis' lead program, glial cell-line derived neurotrophic factor (GDNF), is a potentially disease-modifying treatment for Parkinson's disease that has recently completed Phase 2 clinical studies. The program is the first to use MedGenesis' proprietary intermittent convection-enhanced delivery (CED) paradigm for targeted, local drug administration to the affected brain area.
View Top Employees from MedGenesis Therapeutix Inc.| Website | http://www.medgenesis.com |
| Revenue | $13 million |
| Employees | 4 (1 on RocketReach) |
| Founded | 2005 |
| Address | 730-730 View St, Victoria, British Columbia V8W 3Y7, CA |
| Phone | (250) 386-3000 |
| Fax | (250) 386-3777 |
| Technologies |
JavaScript,
HTML,
ASP.NET
+5 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Biopharma, Pharmaceuticals, Healthcare, Health Care, Science and Engineering, Pharmaceutical |
| Competitors | AGY Therapeutics, Inc., Allena Pharmaceuticals, Inc., Boston Life Sciences Inc, Supernus Pharmaceuticals, Inc., Vanda Pharmaceuticals |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular MedGenesis Therapeutix Inc. employee's phone or email?
MedGenesis Therapeutix Inc. Questions
The MedGenesis Therapeutix Inc. annual revenue was $13 million in 2024.
1 people are employed at MedGenesis Therapeutix Inc..
MedGenesis Therapeutix Inc. is based in Victoria, British Columbia.
The NAICS codes for MedGenesis Therapeutix Inc. are [3254, 32541, 32, 325].
The SIC codes for MedGenesis Therapeutix Inc. are [283, 28].
Related Companies
